Morphine (3.0 mg/kg, SC) stimulates locomotor activity in rats, and this effect sensitizes with repeated intermittent treatment. We examined the ability of the AMPA antagonist LY293558, administered systemically over a range of doses (0.1-3.0 mg/kg), to alter morphine sensitization. Pretreatment wit
β¦ LIBER β¦
Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine
β Scribed by Yong Li; A. John Vartanian; Francis J. White; Chang-Jiang Xue; M. E. Wolf
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 410 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
AMPA antagonist LY293558 blocks the deve
β
William A. Carlezon Jr.; Kurt Rasmussen; Eric J. Nestler
π
Article
π
1999
π
John Wiley and Sons
π
English
β 68 KB
Cholecystokinin modulates both the devel
β
G. R. Wunderlich; N. J. DeSousa; F. J. Vaccarino
π
Article
π
2000
π
Springer
π
English
β 85 KB
Development of both conditioning and sen
β
Jane Stewart; Jonathan P. Druhan
π
Article
π
1993
π
Springer
π
English
β 914 KB
Effects of group I metabotropic glutamat
β
Olga A. Dravolina; Wojciech Danysz; Anton Y. Bespalov
π
Article
π
2006
π
Springer
π
English
β 174 KB
Dissociable effects of the ΞΊ-opioid rece
β
Louk J.M.J. Vanderschuren; Anton N.M. Schoffelmeer; George Wardeh; Taco J. De Vr
π
Article
π
2000
π
Springer
π
English
β 119 KB
The effect of the non-NMDA receptor anta
β
Nick DΓΌrmΓΌller; Mike Craggs; Brian S. Meldrum
π
Article
π
1994
π
Elsevier Science
π
English
β 817 KB
A competitive (NBQX) and a non-competitive (GYKI 52466) AMPA antagonist, and a competitive NMDA antagonist (D-CPPene) were tested against the development of kindling and against fully kindled seizures in amygdala-kindled rats. GYKI 52466, 10 mg/kg given i.p. 5 min prior to electrical stimulation in